Azer Hussain, PhD

Azher Hussain is the Head of Quantitative Pharmacology and Pharmacometrics, Immune-oncology group at Merck. Azher has 20 years of experience in pharmaceutical industry primarily in pharmacokinetics, pharmacodynamics, pharmacometrics and metabolism across small and large molecules. Azher has received his PhD from University of Missouri-Kansas City in 2001. After his post-doctoral training at XenoTech, he worked at Wyeth for 6 years. He joined Merck in 2009 and assumed increasing responsibility. His group is responsible for ensuring model-based quantitative approaches are implemented to advance Merck’s oncology portfolio efficiently across different milestones from first in human to registration.